INSMED Inc·4

May 15, 4:07 PM ET

Desjardins Clarissa 4

4 · INSMED Inc · Filed May 15, 2026

Research Summary

AI-generated summary of this filing

Updated

INSMED (INSM) Director Clarissa Desjardins Receives RSU Award

What Happened
Clarissa Desjardins, a director of INSMED Inc (INSM), received an award of 3,305 restricted stock units (RSUs) on May 13, 2026 (transaction code A — award/grant). The grant was issued for no consideration; the filing does not state a per-share dollar value. These RSUs represent a contingent right to receive one share of common stock per RSU upon vesting.

Key Details

  • Transaction date: May 13, 2026; Form 4 filed May 15, 2026 (timely filing).
  • Award: 3,305 RSUs granted (no cash paid).
  • Vesting: RSUs vest in full on the first anniversary of the grant date, subject to (a) Desjardins remaining a board member until the earlier of that anniversary or the Company's annual meeting in that year, and (b) attending at least 75% of board meetings between grant and the first anniversary (see footnote F1).
  • Consideration: Grant made for no consideration (footnote F2).
  • Shares owned after transaction: not specified in the filing.
  • Exhibit: Power of Attorney included on the filing.

Context
RSU awards to directors are a form of non-cash compensation and do not result in immediate ownership of shares until they vest; they are routine for board pay and should not be interpreted as an immediate buy/sell signal. The reported grant increases potential future equity exposure if vesting conditions are met.

Insider Transaction Report

Form 4
Period: 2026-05-13
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-05-13+3,30570,312 total
Holdings
  • Common Stock

    (indirect: By Spouse)
    3,025
Footnotes (2)
  • [F1]Represents Restricted Stock Units (RSUs), each representing a contingent right to receive one share of Common Stock. The RSUs vest in full on the first anniversary of the grant date (the Vesting Date), provided that the director (a) remains a member of the Board of Directors of the issuer until the earlier of (i) such Vesting Date and (ii) the Company's Annual Shareholder Meeting in the year of such Vesting Date, and (b) attends at least 75% of the meetings of the Board of Directors which take place between the grant date and the first anniversary of the grant date.
  • [F2]Each RSU was granted on May 13, 2026, for no consideration.
Signature
/s/ Clarissa Desjardins, Ph.D., by Michael A. Smith as Attorney-in-fact|2026-05-15

Documents

2 files